Hassanein, Tarek <br/><br/>
A randomized trial of daclatasvir in combination with asunaprevir and beclabuvir in patients with chronic hepatitis C virus genotype 4 infection.  [electronic resource] 

 -  Journal of hepatology  May 2015 
 - 1204-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Letter; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1600-0641 
<br/><br/><label>Standard No.: </label>10.1016/j.jhep.2014.12.025  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--administration & dosage<br/>Benzazepines--administration & dosage<br/>Carbamates<br/>Drug Monitoring<br/>Drug Resistance, Viral<br/>Enzyme Inhibitors--administration & dosage<br/>Female<br/>Hepacivirus--drug effects<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Imidazoles--administration & dosage<br/>Indoles--administration & dosage<br/>Isoquinolines--administration & dosage<br/>Male<br/>Middle Aged<br/>Pyrrolidines<br/>Sulfonamides--administration & dosage<br/>Treatment Outcome<br/>Valine--analogs & derivatives